 Provider News CaliforniaSeptember 2024 Provider Newsletter Contents
CABC-CDCRCM-065267-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Doula services are aimed at preventing perinatal complications and improving health outcomes for birthing parents and infants. The Department of Health Care Services (DHCS) added doula services as a covered benefit in January 2023. Doula services require a recommendation or referral by a physician or other licensed practitioner. Doulas are birth workers who provide health education, advocacy, and physical, emotional, and non-medical support for pregnant and postpartum persons before, during, and after childbirth, including support during miscarriage, stillbirth, and abortion. They are not licensed and do not require supervision. Doulas: - May provide services for up to 12 months from the end of pregnancy; beneficiaries are eligible to receive full-scope Medi-Cal Managed Care (Medi-Cal) coverage for at least 12 months after pregnancy.
- Provide person-centered, culturally competent care that supports the racial, ethnic, linguistic, and cultural diversity of members while adhering to evidence-based best practices.
- Offer various types of support, including health navigation, lactation support, development of a birth plan, and linkages to community-based resources.
Visit the California Advancing and Innovating Medi-Cal (CalAIM) page of our website for additional information about our Doula Program and doula resources, including a provider guide, provider manual, benefit recommendation form, and flyer. We encourage you to share doula services information with your patients. Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-057424-24 Effective December 1, 2024, Anthem is enhancing its claim edits system to ensure claims billed with pharmaceutical drug procedure codes are reported with the appropriate FDA-approved indicators for on- and off-label use. These enhanced claim edits provide an opportunity for Anthem to evaluate submitted claims for drug quality, safety, and effectiveness. The enhancement is to have the claims deny if not billed with FDA indicator for on/off label use. If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will need to submit only the portion(s) of the medical record that is relevant to the drug provided. If you have questions about this notification, contact your contract manager or provider relationship management account representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-063010-24-CPN62565 - Enhanced provisions in member eligibility such as verifying eligibility, children’s benefits, sensitive services, and telehealth
- Adjustments to special programs including managed long-term services, enhanced care management, street medicine, and palliative care
- Changes in multiple areas such as care provider procedures, administrative procedures, utilization management, care management, claims, state-directed payments, and regulatory requirements
The new Provider Operations Manual is now live on our provider website. This recently updated manual contains everything you need to know about our programs and how we work with you to provide quality care to our members. You can access the provider manual here. Several important updates were made this year that we encourage you to review. These include the following: - Member eligibility:
- Verifying eligibility:
- New language added reminding care providers they must review Medi-Cal eligibility for every member for the presence of Other Health Coverage (APL 22-027)
- Updated member ID cards (for Los Angeles and non-Los Angeles) (new design
- Children’s Benefits (new):
- New subsection was added to incorporate different types of children’s benefits (California Children’s Services, Medi-Cal for Kids & Teens, and childhood lead exposure testing)
- Sensitive services:
- Abortion services are covered by the Medi-Cal program. Anthem will not deny or interfere with a member’s right to choose or obtain an abortion prior to viability of the fetus or when an abortion is necessary to protect the life or health of the pregnant individual. In addition, Anthem will not require a care provider to perform an abortion (APL 24-003).
- New language added regarding care providers being prohibited from sharing, selling, marketing, or using any medical information about gender-affirming care, abortion, or any related services (AB 254 and AB 352)
- Telehealth:
- New language added for care providers who offer telehealth services requiring in-person care or to arrange for a referral to in-person care if member does not want to proceed with a telehealth visit (APL23-007 and AB 1241)
- Doula, community health, and asthma preventive services can be conducted through telehealth (DHCS Telehealth Manual).
- Transportation:
- Members should schedule ride services at least five business days in advance, 10 business days in advance for long-distance appointments (exceptions apply: dialysis, chemotherapy, radiation therapy, urgent care, wound care, or facility discharges) (ModivCare).
- Special Programs:
- Managed long-term services and supports:
- Subdivision added to the topic of Intermediate Care Facilities for Developmentally Disabled (ICF/DD) (APL23-023)
- Enhanced care management:
- Removed the following population of focus: individuals with intellectual and developmental disabilities and pregnancy and postpartum individuals at risk of adverse perinatal outcomes
- Street medicine:
- New subsection added on street medicine (APL 24-001)
- Palliative care program:
- Hospice care providers may bill for medically necessary palliative care services for eligible Medi-Cal beneficiaries diagnosed with serious or life-threatening illnesses (DHCS Bulletin).
- Care provider procedures and responsibilities:
- More language on balance billing added: care providers are prohibited from billing eligible members for covered services and billing dual-eligible beneficiaries for Medicare, and members may not pay for medical care (Cal Code of Regulation, 14019.4)
- Access to care, appointment standards, and after-hours services:
- To comply with AB1740, language was added regarding care providers posting a human trafficking notice (AB1740).
- Required Assessments:
- Removed CCS language and moved to children’s benefits
- Administrative procedures:
- Updating provider directories:
- New language added on updating delegate contact list (new DHCS contract requirement)
- Utilization management and prior authorization:
- Authorization request and time frames:
- New language added regarding the preferred method for digital submission of preauthorization requests (Availity Essentials authorization)
- Transition and discharge planning:
- New language added regarding ADT data (admission, discharge, transfer) (APL22-026)
- Care management and health programs:
- Health services programs:
- Updated language on New Baby, New Life
- Claims and encounters:
- Claim submissions:
- Language added regarding how much interest is paid if a clean claim is not processed promptly (APL23-020)
- New subdivision added on electronic visit verification (APL 22-014)
- Encounters:
- Subsection title changed from encounters data to encounters
- State-directed payments:
- Proposition 56:
- Language changes made for state-directed payments
- Grievances, appeals, disputes:
- Member appeals and grievances:
- Removed Los Angeles County (for L.A. Care) regarding where to file grievances; all grievances must go to a Medi-Cal office now
- New language added on Medi-Cal member appeals state hearings
- Compliance and regulatory requirements:
- Marketing rules:
- Anthem will no longer seek approval from Managed Risk Medical Insurance Board (MRMIB) on Anthem-branded marketing materials for Medi-Cal patients.
While we strive to keep our Provider Operations Manual current, please be sure to check our provider website for the most up-to-date plan policy information. If you have questions about the provider manual or provider bulletins, contact your provider relationship management representative or call one of our Medi-Cal Customer Care Centers at 800‑407‑4627 (outside L.A. County) or 888-285-7801 (in L.A. County). Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-064192-24 Beginning with claims processing on or after December 1, 2024, we are enhancing our claims edits system to ensure that claims billed with pharmaceutical drug procedure codes are reported with the appropriate Federal Drug Administration (FDA)-approved indicators for on- and off-label use. What are the purposes of the enhanced claim edits?These enhanced claim edits offer an opportunity for us to evaluate submitted claims for drug quality, safety, and effectiveness. The enhancement is designed to deny claims if they are not billed with the FDA indicator for on- and off-label use. What steps should I take if I disagree with a claim reimbursement decision?If you believe a claim reimbursement decision should be reviewed, follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will only need to submit the portion(s) of the medical record that is relevant to the drug provided. With your help, we can continually build towards a future of shared success. If you have questions, contact your provider relationship management account representative. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-063791-24-CPN63211 Claims that are submitted for laboratory services subject to the Clinical Laboratory Improvement Amendments of 1988 (CLIA) statute and regulations require additional information to be considered for payment. To be considered for reimbursement of clinical laboratory services, a valid CLIA certificate identification number must be reported on a 1500 Health Insurance Claim Form (CMS-1500) or its electronic equivalent for clinical laboratory services. The CLIA certificate identification number must be submitted in one of the following manners: Claim format and elements | CLIA number location options | Referring provider name and NPI number location options | Servicing laboratory physical location | CMS-1500 (formerly HCFA-1500) | Must be represented in field 23 | Submit the referring provider name and NPI number in fields 17 and 17b, respectively. | Submit the servicing provider name, full physical address and NPI number in fields 32 and 32A, respectively, if the servicing address is not equal to the billing provider address. The servicing provider address must match the address associated with the CLIA ID entered in field 23. | HIPAA 5010 837 Professional | Must be represented in the 2300 loop, REF02 element, with qualifier of X4 in REF01 | Submit the referring provider name and NPI number in the 2310A loop, NM1 segment. | Physical address of servicing provider must be represented in the 2310C loop if not equal to the billing provider address and must match the address associated with the CLIA ID submitted in the 2300 loop, REF02. |
To be considered for reimbursement of reference laboratory services, the referring laboratory must be an independent clinical laboratory. Modifier 90 must be submitted to denote the referred laboratory procedure. Per the Centers for Medicare & Medicaid (CMS), an independent clinical laboratory that submits claims in paper format may not combine non-referred or self-performed and referred services on the same CMS-1500 claim form. Thus, when the referring laboratory bills for both non-referred and referred tests, it must submit two separate paper claims: one claim for non-referred tests and the other for referred tests. If submitted electronically, the reference laboratory must be represented in the 2300 or 2400 loop, REF02 element, with qualifier of F4 in REF01. Providers who have obtained a CLIA Waiver or Provider Performed Microscopy Procedure accreditation must include the QW modifier when any CLIA waived laboratory service is reported on a CMS-1500 claim form. Laboratory procedures must be rendered by an appropriately licensed or certified laboratory having the appropriate level of CLIA accreditation for the particular test performed. Thus, any claim that does not contain the CLIA ID, has an invalid ID, has a lab accreditation level that does not support the billed service code, does not have complete servicing provider demographic information and/or applicable reference laboratory provider demographic information, will be considered incomplete and rejected or denied. If you have questions, please contact your Provider Relationship Management representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CRCM-029652-23-CPN29126, CABC-CD-029250-23-CPN29147, CABC-CDCRCM-066924-24 Summary:- The Consolidated Appropriations Act (CAA) obliges providers to validate their online directory details every 90 days to remain listed.
- Anthem's provider data management (PDM) on Availity Essentials enables providers to verify and update their information efficiently.
- Providers can submit data updates through the PDM's Roster Automation solution using a standard Microsoft Excel document.
The CAA of 2021 requires providers to review and verify the accuracy of the following information in the online provider directory every 90 days: - Provider/facility name
- Address
- Specialty
- Phone number
- Digital contact information
Providers who fail to verify their information every 90 days may be removed from the online provider directory. Providers will be reinstated to the online provider directory once verification is complete. Review, verify, and update your directory informationTo review, verify, and update your online directory information, Anthem uses the provider data management (PDM) capabilities of Availity Essentials to update provider or facility data. Using the Availity PDM application meets the verification requirement to validate provider demographic data set by the CAA. PDM features include: - Updating provider demographic information for all assigned payers in one location.
- Verifying and managing current provider demographic information.
- Monitoring submitted demographic updates in real-time with a digital dashboard.
- Reviewing the history of previously verified data.
To access the PDM application, log on to Availity and go to My Providers > Provider Data Management Administrators are automatically granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information. View the Availity PDM quick start guide here (PDF). Use Roster Automation to submit provider demographic changesWithin the PDM application, providers also have the choice and flexibility to request data updates using our Roster Automation solution by submitting a spreadsheet via a roster upload. Provider data additions, changes, and terminations are submitted on a standardized Microsoft Excel document. The resources for this process are available on our website. Visit anthem.com > For Providers > Forms and Guides. The following two resources appear under the Digital Tools category: - Roster Automation Rules of Engagement: This is a reference document available to ensure error-free submissions for accurate and timely updates through automation.
- Roster Automation Standard Template: Use this template to submit your information. More detailed instructions on formatting and submission requirements can be found on the first tab of the template, the tab named User Reference Guide.
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-064386-24-SRS64386 Beginning with dates of services on or after August 10, 2024, we will update our claims editing process for outpatient facility claims by applying the Medicare National Correct Coding Initiative (NCCI) medically unlikely edits (MUE). NCCI edits are Centers for Medicare & Medicaid Services (CMS) developed guidelines to promote national correct coding based on industry standards for current coding practices. These edits provide an opportunity to shift certain existing back-end reviews to front-end adjudication for outpatient facility claims. While this may facilitate quicker claim adjudication, it may also cause claims to deny frequency unit limits tied to MUE if correct coding guidelines are not followed. For additional information, please visit CMS.gov and select the Medically Unlikely Edits page. If you have questions about this communication or need assistance with any other item, contact your provider relationship management representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-063425-24 At a glance:Last month, we published information about the Consolidated Appropriations Act (CAA) data attestation process for Commercial providers here. This article provides additional information for Commercial, Medicaid, and Medicare Advantage providers about updating your provider data with us.Care providers contracted with us must verify or update their demographic data every 90 days using the Provider Data Management (PDM) capability on Availity Essentials for efficient claims processing and timely reimbursement. California providers also have the option to submit updates via Symphony’s file-based data exchange (or via their premium service for a fee).Updating and attesting data are critical for maintaining accurate service directories for members. Non-compliance with these requirements may result in removal from the online provider directory.Availity Essentials not only allows for data attestation but also provides digital applications that enable users to monitor submitted demographic updates in real time, review the history of previously verified data, and manage multiple updates within one spreadsheet via the Upload Roster feature.
What are the requirements for the attestation of demographic data?We require our contracted care provider partners to attest to their demographic data every 90 days. Maintaining your provider data is critical as it results in improved connection to members seeking care, supports the accuracy of claims processing, and allows for timely reimbursement, while aligning to a bold purpose of improving the health of humanity. How do I update and attest to my data?We require the use of the PDM capability available on Availity Essentials to update your provider or facility data. There are two options within Availity Essentials PDM that are available at no cost to care providers: - Multi-payer platform, which includes Directory Verification and Core PDM: allows care providers to make required updates using Directory Verification and changes using Core PDM
- Roster upload: allows care providers to submit multiple updates within one spreadsheet via the Upload Roster feature (the Upload Roster feature is currently only available and shared with the health plan)
Both the multi-payer platform and Roster Upload feature satisfy your 90-day attestation requirement. To attest to your provider data: - Log in to Availity Essentials.
- Navigate to My Providers > Provider Data Management.
- Select the action menu next to the business whose information you want to verify.
- Select Verify Directory Listing.
- Review each set of data for accuracy.
- Once complete, select Submit Verified Profile.
Organizations with no changes since their last submission may see a Quick Verify button that allows for directory verification in one click. Individuals registered for their TIN within the Availity Manage My Organization application on Availity Essentials will receive periodic automated emails and notifications in the Notification Center on Availity reminding them when their attestation is due or overdue. California providers also have the option to submit updates and attest to data via Symphony’s file-based data exchange (or via their premium service for a fee). Contact the Symphony team here. How do I access Availity Essentials and the PDM application?To access the PDM application, log on to Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information. Within PDM you also have the ability to: - Monitor submitted demographic updates in real time with a digital dashboard.
- Review the history of previously verified data.
Why is updating and attesting to my data important?Our members use Find Care to make informed decisions about their healthcare and find quality doctors and hospitals. Keeping your data up to date ensures members have access to you when they need it the most. Failure to complete the 90-day attestation requirement puts your organization at risk of being classified as non-compliant with the health plan’s policies and procedures and may result in removal from the online provider directory. What if I’m not registered for Availity yet?If you aren’t registered to use Availity Essentials, signing up is easy and secure. There is no cost to register or to use any of the digital applications. Start by going to Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one TIN, ensure you have registered all TINs associated with your account. If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY (282-4548). How do I get training on the Availity PDM tool?You can learn about and attend one of our training opportunities by visiting here: - For more information on Availity PDM, check out the Quick Start Guide here using your Availity Essentials user ID and password.
- For more information about the Roster Upload process:
- See the Roster Submission Guide on Availity.com > Payer Spaces > Select Payer Tile > Resources > Roster Submission Guide using PDM.
- Find training specifically for the Standard Template and Rules of Engagement by listening to our recorded webinar here.
- Take an on-demand class hosted by Availity to learn about Provider Data Management here.
Contact us Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to Availity.com and select the appropriate Payer Spaces tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat. We are committed to finding solutions that help our care provider partners offer quality services to our members. For additional support, visit the Contact Us section of our provider website for the appropriate contact. Carelon Behavioral Health, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCRCM-065674-24-CPN65572 Improvements in search capabilities in Availity Essentials now result in faster and more accurate results. To help save you more time upfront while receiving more detailed eligibility & benefits information, we’ve expanded the Current Procedural Terminology® (CPT) code search capabilities in Availity Essentials’ Eligibility and Benefit tool. These optimizations enable the use of up to eight specific CPT or Healthcare Common Procedure Coding System (HCPCS) codes per transaction for faster, more accurate, and personalized search results, which include: - Authorization requirement notifications — so you know up-front if an authorization is needed.
- Additional plan-level benefit limitations details.
- Cost-share information displayed by places of service and procedure codes.
Making these details available on the search results pages can help you save time and effort by giving you access to the right information you need when you need it. Additionally, it reduces the need to contact us, resulting in fewer calls and chats over time. Watch the recorded training to see how you can start saving time today. Learning sessions show step-by-step how you can use the CPT code search capabilities in Availity Essentials to help increase your productivity. We're dedicated to supporting your success through digital solutions that help reduce your administrative burden and streamline your interactions with us. If you have any questions, contact your provider relationship management representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCRCM-062259-24-CPN60904 Fifty-three million, or more than one in five Americans, are family caregivers. Caregiving in the U.S. 2020 reports that caregivers face health challenges of their own, with nearly a quarter of caregivers finding it hard to take care of their own health and saying that caregiving has made their own health worse. Now, we have made it easy for providers to help their patients who are family caregivers reduce their stress and improve their health. Help for Cancer Caregivers’ new healthcare provider landing page has an easy-to-download flyer that can be given to patients to encourage them to visit Help for Cancer Caregivers. This evidence-based, interactive website allows family caregivers to take a brief survey to create a personal self-care guide, access social services, and browse topics like dealing with feelings, keeping health, day-to-day needs, working together, and long-distance caregiving. Studies show that family caregivers suffer from poorer physical health than those who do not have additional caregiving responsibilities. Studies have found that: - Caregivers show higher levels of depression.
- Caregivers suffer from high levels of stress and frustration, which can lead to burnout.
- Stressful caregiving situations may lead to harmful behaviors, such as abusing drugs or alcohol.
- Caregivers have an increased risk of heart disease.
- Caregivers have lower levels of self-care.
- Chronic diseases of caregivers are often more difficult to manage.
- Caregivers have an increased risk of sickness and premature death.
Evidence has also shown that education and intervention reduce caregiver strain, uncertainty, and helplessness and that information helps normalize the caregiver experience and enhances a sense of control. Access the healthcare provider landing page today. This website includes language and accessibility tools to support non-English speakers and people with accessibility needs. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-064164-24-CPN64037 Effective October 25, 2024 Summary: On November 17, 2023, and March 21, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email. Please see the explanation or definition for each category of Clinical Criteria below: - New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | October 25, 2024 | *CC-0261 | Winrevair (sotatercept-csrk) | New | October 25, 2024 | *CC-0125 | Opdivo (nivolumab) | Revised | October 25, 2024 | *CC-0003 | Immunoglobulins | Revised | October 25, 2024 | CC-0033 | Xolair (omalizumab) | Revised | October 25, 2024 | *CC-0062 | Tumor Necrosis Factor Antagonists | Revised | October 25, 2024 | CC-0121 | Gazyva (obinutuzumab) | Revised | October 25, 2024 | CC-0201 | Rybrevant (amivantamab-ymjw) | Revised | October 25, 2024 | *CC-0251 | Ycanth (cantharidin) | Revised |
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-060427-24-CPN59849 Effective November 14, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter 1, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Provider Medical Policies | Anthem.com. Notes/updates:Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive. - LAB.00039 - Combined Pathogen Identification and Drug Resistance Testing; Previously Titled: Pooled Antibiotic Sensitivity Testing:
- Revised title
- Revised Position Statement to address “combined pathogen identification and drug resistance” testing
- OR-PR.00008 - Osseointegrated Limb Prostheses:
- Outlines the Medically Necessary and Not Medically Necessary criteria for the use of osseointegrated (bone-anchored) prosthetic devices for improving the mobility and function of people who have had limb loss.
- SURG.00052 - Percutaneous Vertebral Disc and Vertebral Endplate Procedures:
- Revised Medically Necessary criteria for basivertebral nerve ablation (BVNA)
- SURG.00162 - Implantable Shock Absorber for Treatment of Knee Osteoarthritis:
- Use of an implantable shock absorber device for treatment of osteoarthritis of the knee is considered Investigational & Not Medically Necessary.
- CG-DME-53 - Biomechanical Footwear Therapy:
- Biomechanical footwear therapy is considered Not Medically Necessary for all indications.
- CG-LAB-32 - Cancer Antigen 125 Testing:
- Outlines the Medically Necessary and Not Medically Necessary criteria for the tumor marker cancer antigen 125 (CA-125) testing.
- CG-MED-94 - Vestibular Function Testing:
- Revised Medically Necessary and Not Medically Necessary statements to include vestibular-evoked myogenic potential tests
- CG-MED-96 - Prefabricated External Infant Ear Molding Systems:
- Outlines the Medically Necessary, Reconstructive and Cosmetic & Not Medically Necessary criteria for the use of prefabricated external infant ear molding systems to treat external ear malformations and deformations.
Medical PoliciesOn February 15, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These Medical Policies take effect November 14, 2024. Publish date | Medical Policy number | Medical Policy title | New or revised | 4/10/2024 | *LAB.00039 | Combined Pathogen Identification and Drug Resistance Testing Previously Titled: Pooled Antibiotic Sensitivity Testing | Revised | 2/22/2024 | MED.00140 | Gene Therapy for Beta Thalassemia | Revised | 4/10/2024 | *OR-PR.00008 | Osseointegrated Limb Prostheses | New | 4/1/2024 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Revised | 4/10/2024 | *SURG.00052 | Percutaneous Vertebral Disc and Vertebral Endplate Procedures | Revised | 4/10/2024 | SURG.00145 | Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts) | Revised | 4/10/2024 | *SURG.00162 | Implantable Shock Absorber for Treatment of Knee Osteoarthritis | New | 4/10/2024 | TRANS.00028 | Hematopoietic Stem Cell Transplantation for Hodgkin Disease and non-Hodgkin Lymphoma | Revised |
Clinical UM GuidelinesOn February 15, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Anthem members on March 28, 2024. These guidelines take effect November 14, 2024. Publish date | Clinical UM Guideline number | Clinical UM Guideline title | New or revised | 4/10/2024 | CG-DME-50 | Automated Insulin Delivery Systems | Revised | 4/10/2024 | *CG-DME-53 | Biomechanical Footwear Therapy | New | 4/10/2024 | *CG-LAB-32 | Cancer Antigen 125 Testing | New | 4/10/2024 | CG-MED-68 | Therapeutic Apheresis | Revised | 4/10/2024 | *CG-MED-94 | Vestibular Function Testing | Revised | 4/10/2024 | *CG-MED-96 | Prefabricated External Infant Ear Molding Systems | New | 4/10/2024 | CG-SURG-118 | Intraocular Anterior Segment Aqueous Drainage Devices (without extraocular reservoir) | Conversion new | 4/10/2024 | CG-SURG-119 | Treatment of Varicose Veins (Lower Extremities) | Conversion new | 4/10/2024 | CG-SURG-120 | Vagus Nerve Stimulation | Conversion new | 4/10/2024 | CG-SURG-121 | Fetal Surgery for Prenatally Diagnosed Malformations | Conversion new | 4/1/2024 | CG-SURG-78 | Locoregional Techniques for Treating Primary and Metastatic Liver Malignancies | Revised |
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-062709-24-CPN62336 Effective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0420U | Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma | 0422U | Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate Guardant360 Response™, Guardant Health, Inc, Guardant Health, Inc | 0423U | Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition Genomind® Pharmacogenetics Report – Full, Genomind®, Inc, Genomind®, Inc | 0428U | Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden Epic Sciences ctDNA Metastatic Breast Cancer Panel, Epic Sciences, Inc, Epic Sciences, Inc | 0430U | Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative Malabsorption Evaluation Panel, Mayo Clinic/Mayo Clinic Laboratories, Mayo Clinic/Mayo Clinic Laboratories | 0435U | Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations ChemoID®, ChemoID® Lab, Cordgenics, LLC | 0790T | Revision (eg, augmentation, division of tether), replacement, or removal of thoracolumbar or lumbar vertebral body tethering, including thoracoscopy, when performed | 0810T | Subretinal injection of a pharmacologic agent, including vitrectomy and 1 or more retinotomies | 0815T | Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine | 0823T | Transcatheter insertion of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography | 0824T | Transcatheter removal of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography), when performed | 0825T | Transcatheter removal and replacement of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed | 0826T | Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional, leadless pacemaker system in single-cardiac chamber | 0861T | Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; both components (battery and transmitter) | 0862T | Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only | 0863T | Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only | 0864T | Low-intensity extracorporeal shock wave therapy involving corpus cavernosum, low energy | 22836 | Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; up to 7 vertebral segments | 22837 | Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; 8 or more vertebral segments | 22838 | Revision (eg, augmentation, division of tether), replacement, or removal of thoracic vertebral body tethering, including thoracoscopy, when performed | 31242 | Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve | 31243 | Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve | 33276 | Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed | 33279 | Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) only | 33281 | Repositioning of phrenic nerve stimulator transvenous lead(s) | 33287 | Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator | 33288 | Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) | 37242 | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquired arterial malformations, arteriovenous malformations, arteriovenous fistulas, aneurysms, pseudoaneurysms) [when specified as genicular artery embolization] | 81517 | Liver disease, analysis of 3 biomarkers (hyaluronic acid [HA], procollagen III amino terminal peptide [PIIINP], tissue inhibitor of metalloproteinase 1 [TIMP-1]), using immunoassays, utilizing serum, prognostic algorithm reported as a risk score and risk of liver fibrosis and liver-related clinical events within 5 years Enhanced Liver Fibrosis™ (ELF™) Test, Siemens Healthcare Diagnostics Inc/Siemens Healthcare Laboratory LLC | 93150 | Therapy activation of implanted phrenic nerve stimulator system, including all interrogation and programming | 93151 | Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system | 93152 | Interrogation and programming of implanted phrenic nerve stimulator system during polysomnography | 93153 | Interrogation without programming of implanted phrenic nerve stimulator system | E0746 | Electromyograph Biofeedback | L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control | Q4279 | Vendaje ac, per square centimeter | Q4287 | Dermabind dl, per square centimeter | Q4288 | Dermabind ch, per square centimeter | Q4289 | Revoshield + amniotic barrier, per square centimeter | Q4290 | Membrane Wrap-Hydro TM, per sq cm | Q4291 | Lamellas xt, per square centimeter | Q4292 | Lamellas, per square centimeter | Q4293 | Acesso dl, per square centimeter | Q4294 | Amnio quad-core, per square centimeter | Q4295 | Amnio tri-core amniotic, per square centimeter | Q4296 | Rebound matrix, per square centimeter | Q4297 | Emerge matrix, per square centimeter | Q4298 | Amnicore pro, per square centimeter | Q4299 | Amnicore pro+, per square centimeter | Q4300 | Acesso tl, per square centimeter | Q4301 | Activate matrix, per square centimeter | Q4302 | Complete aca, per square centimeter | Q4303 | Complete aa, per square centimeter | Q4304 | Grafix plus, per square centimeter |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/ca/provider/medicare-advantage on the Resources tab or for contracted providers by accessing Availity.com. UM AROW A2024M1469 Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-057222-24-CPN56904 Effective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medi-Cal Managed Care members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 33263 | Removal Of Pacing Cardioverter-Defibrillator Pulse Generator With Replacement Of Pacing Cardioverter-Defibrillator Pulse Generator; Dual Lead System | 64582 | Open implantation of hypoglossal nerve neurostimulator array, pulse generator, and distal respiratory sensor electrode or electrode array | C2616 | Brachytherapy source, nonstranded, yttrium-90, per source when specified as yttrium-90 microspheres |
To request PA, you may use one of the following methods: - Web: once logged in at Availity.com
- Fax: 800-754-4708
- Phone: 888-831-2246 — Medi-Cal, 877-273-4193 — MRMIP
Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/ca on the Resources tab or contracted providers can access Availity.com. Providers may also call Medi-Cal Customer Care Centers for assistance with PA requirements: - Outside L.A. County: 800-407-4627
- L.A. County: 888-285-7801
UM AROW A2024M1414 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-059301-24-CPN58059 Anthem is excited to announce the development of the Blue National Physician Performance Dataset. This initiative is a collaborative approach between Blue Cross Blue Shield Association, Blue Health Intelligence (BHI), and Motive Medical Intelligence (MMI) to develop a consistent national approach to evaluating physicians at the National Provider Identifier (NPI) level that incorporates measures of quality of care, appropriateness of care, and cost/efficiency of care. Effective January 1, 2025, Anthem may incorporate the Blue National Physician Performance Dataset in various ways, including but not limited to: - Special opportunities to participate in product offerings.
- When members contact Anthem with requests for referral options.
- Developing provider designations in provider directory (FindCare) tools.
- Enhancing existing tools in FindCare and Cost Finder such as Personalized Match that assist members with identifying or sorting providers.
For more information on how physicians are evaluated within each of the three categories (quality, appropriateness of care, and cost), you can view the Blue National Physician Performance Dataset Evaluation Method. If you have any questions about the Methodology or your score, contact your local provider relationship management representative. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-059173-24-CPN57527, CABC-CM-059172-24-CPN57527 ATTACHMENTS (available on web): Blue National Physician Performance Dataset Evaluation Method (pdf - 0.11mb) Effective for dates of service on or after December 1, 2024, the specialty Medicare Part B drugs listed below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | J1599 | Alyglo (immune globulin intravenous, human-stwk) |
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-064681-24-CPN64482 Effective for dates of service on or after December 1, 2024, the specialty Medicare Part B drugs listed below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | C9399, J9999 | Anktiva (nogapendekin alfa inbekicept-pmln) | J3590 | Hercessi (trastuzumab-strf) | C9399, J9999 | Imdelltra (tarlatamab-dlle) |
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-064671-24-CPN64481 Want to reduce administrative burden and help your patients save on prescription costs? With real-time prescription benefit (RTPB), care providers can access patient-specific drug benefit information within the e-prescribing process. This functionality allows care providers to proactively identify barriers to cost and improve medication adherence. Prescription pickup rates have increased 3.2% and saved patients on average $40 per prescription with using real-time prescription benefit.” — Surescripts.2 When using real-time prescription benefit during e-prescribing, care providers can see patient-specific benefit information including: - Formulary status of selected medication.
- Patient cost share of medication at a retail and mail order pharmacy.
- Up to five formulary drug alternatives.
- Coverage alerts, including prior authorization and step therapy.
Benefits you and your patients will experience when using RTPB:- Clearer, faster information
- Opportunity to lower cost barriers
- Decreased administrative burden
- Reduced time to therapy
- Enhanced patient experience
How real-time prescription benefit works:- Prescriber enters prescription information through e-prescribing.
- The e-prescribing system triggers a data call to the pharmacy benefit manager (PBM).
- The PBM receives the real-time prescription benefit request.
- The PBM delivers cost, formulary, and utilization information for the selected pharmacy back to the prescriber’s electronic health record (EHR).
- Prescriber and patient make a choice together.
Help your patients save money on their prescriptions with EHR access to patient-specific drug coverage and out of pocket costs. Find out if your EHR vendor provides real-time prescription benefits information. There’s no charge for the service; however, you will need the latest version of your EHR. References:- Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018;22:18-033. doi: 10.7812/TPP/18-033. PMID: 30005722; PMCID: PMC6045499.
- Giaquinto K. Prescription Pickup Rates 3.2 Percentage Points Higher with Surescripts Real-Time Prescription Benefit, Saving Patients an Average of $38 Per Prescription. Surescripts. September 2022.
- Rodriguez S. Surescripts real-time prescription benefit drove medication adherence. EHRIntelligence. https://ehrintelligence.com/news/surescripts-real-time-prescription-benefit-drove-medication-adherence?_hsmi=226935530&_hsenc=p2ANqtz--HlMXEGIqFp9czAfA3_Z5V1uCL8ujtrmfRv3mTJ3EhaA0VCsVpQQmK9ifNmgQw4ApI_6rb1_AvlNFyilc9FXXymEO4zpPLFQUikhqNsjxAAA_8INg. Published September 21, 2022. Accessed November 2, 2022.
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-065094-24-CPN64484 Visit the Drug Lists page on our website at anthem.com/ca/ms/pharmacyinformation/home.html for more information about: - Copayment/coinsurance requirements and their applicable drug classes.
- Drug lists and changes.
- Prior authorization criteria.
- Procedures for generic substitution.
- Therapeutic interchange.
- Step therapy or other management methods subject to prescribing decisions.
- Any other requirements, restrictions, or limitations that apply to using certain drugs.
The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October. To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed. Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits. Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access. Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-063413-24 To help make it as easy as possible to keep up with annual changes to HEDIS documentation, Anthem created a library of HEDIS content for you. You’ll find tip sheets with coding information and more for many HEDIS measures and other documentation to help ensure accurate claims coding, which helps ensure accurate reimbursement. Go to the Optimizing HEDIS & STARS category to view all the communications. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CRCM-064521-24-CPN64263 |